OTCMKTS:KPTSF KP Tissue (KPTSF) Stock Price, News & Analysis $9.27 0.00 (0.00%) As of 09/23/2026 03:53 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartNews and Trends About KP Tissue Stock (OTCMKTS:KPTSF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get KP Tissue alerts:Sign Up Key Stats Today's Range$9.27▼$9.2750-Day Range$8.99▼$9.4052-Week Range$6.60▼$9.60Volume102 shsAverage Volume453 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview KP Tissue Inc. is a Canadian company whose principal business is its investment in Kruger Products L.P., a manufacturer and marketer of tissue products. Through this relationship, KP Tissue has exposure to the consumer and away-from-home tissue markets rather than operating as a standalone manufacturer of a broad range of unrelated products. Kruger Products makes bathroom tissue, facial tissue, paper towels, napkins and other paper-based products. Its portfolio includes brands such as Cashmere, Purex, Scotties, SpongeTowels, White Swan and Embassy, along with various products sold under private-label and commercial brands. The business primarily serves customers in Canada and the United States through retail, commercial and institutional channels. Kruger Products operates manufacturing facilities in North America and supplies products for household use as well as workplaces, restaurants, healthcare facilities and other away-from-home settings. The operating company is led by chief executive officer Dino Bianco.AI Generated. May Contain Errors. Read More Receive KPTSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KP Tissue and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KPTSF Stock News HeadlinesKP Tissue Inc KPTSFAugust 7, 2026 | morningstar.comMKP Tissue Inc.: KP Tissue to Release its Financial Results and Those of Kruger Products Inc. for The Second Quarter of 2026July 13, 2026 | finanznachrichten.deMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 people worldwide. His system has flagged a handful of stocks worth watching ahead of September 30th. See which stocks his AI research platform is flagging right now.September 24 at 1:00 AM | TradeSmith (Ad)KP Tissue to Release its Financial Results and Those of Kruger Products Inc. for The Second Quarter of 2026July 13, 2026 | finance.yahoo.comKP Tissue Inc (KPTSF) Q1 2026 Earnings Call Highlights: Strong EBITDA Growth Amid Revenue ChallengesMay 14, 2026 | finance.yahoo.comKP Tissue Inc.: KP Tissue to Release its Financial Results and Those of Kruger Products Inc. For the First Quarter of 2026April 14, 2026 | finanznachrichten.deKP Tissue (KPT) Receives a Hold from CIBCFebruary 21, 2026 | theglobeandmail.comKP Tissue Declares Quarterly Dividend and Highlights Reinvestment PlanFebruary 21, 2026 | theglobeandmail.comSee More Headlines KPTSF Stock Analysis - Frequently Asked Questions How have KPTSF shares performed this year? KP Tissue's stock was trading at $7.6635 at the start of the year. Since then, KPTSF shares have increased by 21.0% and is now trading at $9.27. How do I buy shares of KP Tissue? Shares of KPTSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/24/2026Next Earnings (Estimated)11/12/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorConsumer Staples Industry Household Products Sub-IndustryHousehold Products Current SymbolOTCMKTS:KPTSF CIKN/A Webwww.kptissueinc.com Phone905 812 6900FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (OTCMKTS:KPTSF) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredNASA's ISS Replacement Could Go to This Tiny Space FirmNASA has commissioned SpaceX to decommission the $150 billion International Space Station, but the contract to...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KP Tissue Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KP Tissue With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.